Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Hepatitis C

Free Subscription Articles published in Am J Gastroenterol Retrieve available abstracts of 25 articles: HTML format

Single Articles

May 2022
1. AMPUERO J, Carmona I, Sousa F, Rosales JM, et al
   Correction to: A 2-Step Strategy Combining FIB-4 With Transient Elastography and Ultrasound Predicted Liver Cancer After HCV Cure.
   Am J Gastroenterol. 2022;117:819.
   PubMed    
   
   
   January 2022
2. FAYED A, Hegazy MT, Biard L, Vieira M, et al
   Relapse of HCV-Cryoglobulinemic Vasculitis Following Sustained Viral Response after Interferon-free Direct-Acting Antivirals.
   Am J Gastroenterol. 2022 Jan 29. pii: 00000434-990000000-00234.
   PubMed     Abstract available
   
   
   October 2021
3. LI J, Le MH, Barakat MT, Cheung RC, et al
   The Changing Epidemiology of Liver Disease Among US Children and Adolescents From 1999 to 2016.
   Am J Gastroenterol. 2021;116:2068-2078.
   PubMed     Abstract available
   
   
   September 2021
4. AMPUERO J, Carmona I, Sousa F, Rosales JM, et al
   A 2-Step Strategy Combining FIB-4 With Transient Elastography and Ultrasound Predicted Liver Cancer After HCV Cure.
   Am J Gastroenterol. 2021 Sep 9. pii: 00000434-900000000-98663.
   PubMed     Abstract available
   
   
   
5. CHUANG WL, Hu TH, Buggisch P, Moreno C, et al
   Ledipasvir/Sofosbuvir for 8, 12, or 24 Weeks in Hepatitis C Patients Undergoing Dialysis for End-Stage Renal Disease.
   Am J Gastroenterol. 2021;116:1924-1928.
   PubMed     Abstract available
   
   
   
6. ZAMOR PJ, Brown A, Dylla DE, Dillon JF, et al
   High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence.
   Am J Gastroenterol. 2021;116:1896-1904.
   PubMed     Abstract available
   
   
   August 2021
7. KONSTANTELOS N, Shakeri A, McCormack D, Feld JJ, et al
   Impact of COVID-19 on Prescribing Trends of Direct-Acting Antivirals for the Treatment of Hepatitis C in Ontario, Canada.
   Am J Gastroenterol. 2021;116:1738-1740.
   PubMed     Abstract available
   
   
   June 2021
8. RINALDI L, Messina V, Di Marco V, Iovinella V, et al
   Factors Enhancing Treatment of Hepatitis C Virus-Infected Italian People Who Use Drugs: The CLEO-GRECAS Experience.
   Am J Gastroenterol. 2021;116:1248-1255.
   PubMed     Abstract available
   
   
   April 2021
9. SHARMA S, Saraya A
   Avoiding Beta Blockers in Patients of Hepatitis C Virus-Related Compensated Cirrhosis With Clinically Significant Portal Hypertension After Cure With Antivirals: Are We There Yet?
   Am J Gastroenterol. 2021 Apr 9. pii: 00000434-900000000-98829.
   PubMed    
   
   
   March 2021
10. ROGAL S, Youk A, Agbalajobi O, Zhang H, et al
    Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis.
    Am J Gastroenterol. 2021 Mar 30. pii: 00000434-900000000-98834.
    PubMed     Abstract available
    
    
    February 2021
11. TOSETTI G, Degasperi E, Farina E, D'Ambrosio R, et al
    Decompensation in Direct-Acting Antiviral Cured Hepatitis C Virus Compensated Patients With Clinically Significant Portal Hypertension: Too Rare to Warrant Universal Beta-Blocker Therapy.
    Am J Gastroenterol. 2021 Feb 18. pii: 00000434-900000000-98881.
    PubMed     Abstract available
    
    
    December 2020
12. LI J, Gordon SC, Zhou Y, Boscarino JA, et al
    Sex Differences in Extrahepatic Outcomes After Antiviral Treatment for Hepatitis C.
    Am J Gastroenterol. 2020;Publish Ahead of Print.
    PubMed     Abstract available
    
    
    
13. DESAI N, Rich NE, Jain MK, Blackwell JM, et al
    Randomized Clinical Trial of Inreach With or Without Mailed Outreach to Promote Hepatitis C Screening in a Difficult-to-Reach Patient Population.
    Am J Gastroenterol. 2020;Publish Ahead of Print.
    PubMed     Abstract available
    
    
    October 2020
14. SINN DH, Kang D, Guallar E, Chang Y, et al
    Alcohol Intake and Mortality in Patients With Chronic Viral Hepatitis: A Nationwide Cohort Study.
    Am J Gastroenterol. 2020 Oct 8. doi: 10.14309/ajg.0000000000000966.
    PubMed     Abstract available
    
    
    
15. SHARMA S, Agarwal S, Gunjan D, Kaushal K, et al
    Deciding Among Noninvasive Tools for Predicting Varices Needing Treatment in Chronic Liver Disease: An Analysis of Asian Cohort.
    Am J Gastroenterol. 2020;115:1650-1656.
    PubMed     Abstract available
    
    
    July 2020
16. THULUVATH PJ, Bruno DA, Alukal J, Satapathy SK, et al
    Use of HCV-Positive Livers in HCV-Negative Recipients.
    Am J Gastroenterol. 2020;115:1045-1054.
    PubMed     Abstract available
    
    
    
17. POLANCO NP, Goldberg D
    Transplanting Livers From "HCV-Positive" Donors To HCV-Negative Recipients: Increased Experience But Many Unanswered Questions.
    Am J Gastroenterol. 2020;115:1022-1023.
    PubMed     Abstract available
    
    
    May 2020
18. SAKAI N, Kamimura K, Terai S
    Multiple Tumor-Like Fatty Changes in the Liver Disappeared After Hepatitis C Virus Eradication With Direct-Acting Antiviral Treatment.
    Am J Gastroenterol. 2020 May 22. doi: 10.14309/ajg.0000000000000703.
    PubMed    
    
    
    
19. POLANCO NP, Goldberg D
    Transplanting Livers From "HCV-Positive" Donors To HCV-Negative Recipients: Increased Experience But Many Unanswered Questions.
    Am J Gastroenterol. 2020 May 20. doi: 10.14309/ajg.0000000000000649.
    PubMed     Abstract available
    
    
    March 2020
20. HUANG CF, Lai HC, Chen CY, Tseng KC, et al
    Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).
    Am J Gastroenterol. 2020 Mar 26. doi: 10.14309/ajg.0000000000000606.
    PubMed     Abstract available
    
    
    
21. THULUVATH PJ, Bruno DA, Alukal J, Satapathy SK, et al
    Use of HCV-Positive Livers in HCV-Negative Recipients.
    Am J Gastroenterol. 2020 Mar 3. doi: 10.14309/ajg.0000000000000583.
    PubMed     Abstract available
    
    
    December 2019
22. MORALES-ARRAEZ D, Hernandez-Guerra M
    Electronic Alerts as a Simple Method for Amplifying the Yield of Hepatitis C Virus Infection Screening and Diagnosis.
    Am J Gastroenterol. 2019 Dec 11. doi: 10.14309/ajg.0000000000000487.
    PubMed    
    
    
    November 2019
23. KIDAMBI TD, Chu P, Lee JK, Lin JL, et al
    Immunotherapy-Associated Pseudomembranous Colitis.
    Am J Gastroenterol. 2019;114:1708.
    PubMed    
    
    
    August 2019
24. YOUNOSSI ZM, Stepanova M, Lawitz EJ, Reddy KR, et al
    Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of Life.
    Am J Gastroenterol. 2019 Aug 20. doi: 10.14309/ajg.0000000000000375.
    PubMed     Abstract available
    
    
    
25. CALVARUSO V, Cacciola I, Licata A, Madonia S, et al
    Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? The REAL Experience.
    Am J Gastroenterol. 2019;114:1275-1282.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: